Clinical curative effect of oxaliplatin combined with flurouracil in the treatment of gastrointestinal tumor. (Record no. 24959961)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01464 a2200433 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517034614.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201509s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1011-601X |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Li, Baodong |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20150908 |
245 00 - TITLE STATEMENT | |
Title | Clinical curative effect of oxaliplatin combined with flurouracil in the treatment of gastrointestinal tumor. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Pakistan journal of pharmaceutical sciences |
Date of publication, distribution, etc. | May 2015 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1155-8 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Controlled Clinical Trial; Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | China |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Administration Schedule |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Fluorouracil |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gastrointestinal Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Infusions, Intravenous |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Leucovorin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Organoplatinum Compounds |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Oxaliplatin |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Time Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Liu, Yonggang |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wang, Jinbang |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Xu, Dongli |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Feng, Weiyu |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zhuang, Jing |
773 0# - HOST ITEM ENTRY | |
Title | Pakistan journal of pharmaceutical sciences |
Related parts | vol. 28 |
-- | no. 3 Suppl |
-- | p. 1155-8 |
No items available.